№ lp_1_2_28521
Patient-facing clinical information describing the indication, administration, risks, monitoring, and prescribing arrangements for dienogest within specialist endometriosis services.
Year: 2025
Document type: Patient information sheet
Medication: Dienogest 2 mg tablets
Therapeutic area: Endometriosis, endometriomas, adenomyosis
Intended use: Clinical treatment information
Author: Gynaecology Clinical Network
Approving body: Integrated Medicines Optimisation Committee
Approval date: 19 February 2025
Review date: February 2027
Version: V 1.1 (Accessibility)
Prescribing arrangement: Shared care agreement
Target audience: Patients receiving dienogest treatment
Clinical setting: Hospital and primary care collaboration
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.